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INHIBITION OF STAPHYLOCOCCUS AUREUS BIOFILM BY VARIOVORAX PARADOXUS
Abstract
By Esther Gomez
University of the Pacific
2022
Staphylococcus aureus is one of the leading causes of fatal nosocomial infections. Often,
S. aureus can grow as a biofilm which protects the population from the surrounding
environment. Strains of S. aureus are resistant to virtually all known antibiotics on the market.
Variovorax paradoxus is a soil microbe with many unusual metabolic activities. It has been
previously observed that, V. paradoxus can inhibit the growth of S. aureus when in co-culture.
In this work we report on inhibition of S. aureus biofilm formation by V. paradoxus due to a
suspected inhibitory soluble factor.

4
TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION ....................................................................................................6
Antibiotics ............................................................................................................................6
Current Issue ........................................................................................................................6
Staphylococcus aureus Biofilms ..........................................................................................7
Variovorax paradoxus Properties ........................................................................................9
Bacterial Competition ..........................................................................................................9
Hypothesis..........................................................................................................................11
Chapter 2: Materials & Methods....................................................................................................12
Bacterial Strains and Culture Conditions ...........................................................................12
Mono and Co-Culture Biofilm Inhibition (BI) Assay........................................................12
Filtered Biofilm Culture Supernatant (FBCS) Assay ........................................................13
Heat Denatured FBCS Assay .............................................................................................13
Protein K Treated FBCS Assay .........................................................................................13
Molecular Weight Cutoff Fractionation FBCS Assay .......................................................13
SDS-PAGE ........................................................................................................................14
Microscopy ........................................................................................................................14
Crystal Violet Staining.......................................................................................................14
Quantitative Analysis of V. paradoxus and S. aureus .......................................................15
RNA Extraction .................................................................................................................15
Chapter 3: Results ..........................................................................................................................16
Biofilm Inhibition (BI) Assay ............................................................................................16

5
Filtered Biofilm Culture Supernatant (FBCS) Assay ........................................................17
Heat Denatured FBCS Assay .............................................................................................18
Protein K Treated FBCS Assay .........................................................................................18
Molecular Weight Cutoff Fractionation FBCS Assay .......................................................19
SDS-PAGE ........................................................................................................................19
Transcriptional Expression of V. paradoxus in Mono and Co-culture ..............................19
Chapter 4: Discussion ....................................................................................................................21
Biofilm Inhibition of S. aureus ..........................................................................................21
FBCS Inhibits S. aureus Biofilms......................................................................................22
Transcriptome ....................................................................................................................23
Chapter 5: Conclusion....................................................................................................................25
References ......................................................................................................................................26
Appendix
A. Figures..........................................................................................................................30
B. Tables ...........................................................................................................................46

6
CHAPTER 1: INTRODUCTION

Antibiotics
Antibiotics are found in soil, produced primarily by fungi and bacteria. Essentially all
currently available synthetic or semi-synthetic antibiotics are derived from these sources. Many
bacteria produce antibiotics as secondary metabolites, which are compounds not necessary for
survival. Although secondary metabolites are not required, they are expressed when put under
environmental pressures to provide bacteria with a competitive advantage. It is thought that
secondary metabolites may be used for communicating with related microbes, killing other
microbes, or responding to surrounding insects and plants [9]. Antibiotics are either
bacteriostatic compounds that prevent bacterial growth by inhibiting either DNA/RNA/protein
synthesis or bactericidal compounds that kill bacteria by disrupting the cell membrane or
inhibiting the cell wall [11]. Through the Golden age of antibiotic discovery inevitably came the
rise of antibiotic resistance. Whether the problem stems from overuse or improper disposal of
antibiotics, one thing remains, a prolonged search for novel antibiotics [11, 21, 24]. Recent
studies are searching for antimicrobials in previously searched and unsearched areas revealing
promising antibiotics and scientists are continuing to pursue new possibilities.
Current Issue
It is estimated worldwide that approximately 1.2 million people in 2019 died from a
bacterial infection [15]. This mortality risk is largely due to bacterial antibiotic resistance so
there is a large demand for novel antimicrobial agents. Currently, there is a special focus on
combating biofilm resistance in medical devices [29]. One of the most common antibiotic
resistant biofilm infections is S. aureus nosocomial. This microbe present on our skin is usually
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not harmful, but if it enters other areas such as deep tissues of the bloodstream it can cause
serious infection and even death [1]. Infection rate by S. aureus in 2017 alone was
approximately 200,000 with a 10% mortality rate [12]. It is one of the leading causes of hospital
acquired infections that is often detected from contamination of medical devices with drug
resistant biofilms. These risks are especially grave for patients who undergo surgeries or have
implanted medical devices, as this is a common source of infection. Co-infection of S. aureus
and Pseudomonas aeruginosa is also common in cystic fibrosis patients. This inherited disease
affects approximately 35,000 people in the US today [2]. Cystic fibrosis patients have chronic
thick mucus lining both their airways and digestive system. This genetic disease creates an ideal
environment for microbes to proliferate and form biofilms that are difficult to treat. With no
current success in using known antibiotics, the search for novel antimicrobials or interactions via
antibiosis looks promising. Especially when we consider antimicrobial substances that have
come from microbe-microbe interactions.
Staphylococcus aureus Biofilms
A biofilm is a surface attached bacterial growth that is encased in an extracellular
polymeric substance (EPS) matrix and can persist on abiotic or biotic surfaces. The S. aureus
biofilm developmental cycle consists of five phases: attachment, multiplication, exodus,
maturation, and dispersal. In the attachment phase S. aureus adheres to biotic surfaces via
microbial surface components recognizing adhesive matrix molecules (MSCRAMMs).
Adhering to abiotic surfaces is dependent on charge and can affect overall biofilm development
[14]. After attaching to the surface, the cells go into the multiplication phase, which is an
increase in the number of bacteria present, aided by extracellular proteins. The exodus phase is
the early distribution of most bacterial cells to begin constructing microcolonies. Following
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exodus is the maturation phase, where S. aureus forms mushroom-like microcolonies. Finally in
the dispersal phase, S. aureus has reached its max cell density and quorum sensing signals are
released to break down the extracellular polymeric substance (EPS), dispersing bacterial cells
into the surrounding environment.
S. aureus biofilm resistance stems from its robust EPS. The EPS protects the bacterial
cells from stressful conditions allowing it to thrive and spread at a consistent rate. In addition, S.
aureus strains are often multi-antibiotic resistant. The most significant of these are Methicillin
resistant Staphylococcus aureus (MRSA) which carries a mobile resistance gene cassette
(mecA). Once S. aureus obtains this resistance it is very difficult to treat, and biofilm formation
makes this even more challenging. In a recent study looking for anti-biofilm therapies small
molecules were identified that are associated with inhibition of biofilm formation [29]. An
example of a potential therapeutic molecule on that list is daptomycin which disrupts biofilm
formation by specifically targeting the bacterial cell wall/membrane. There are several enzymes
and molecules that target different aspects of S. aureus biofilm formation such as the cell
survival, cell division, quorum sensing, and extracellular DNA. These are potentially effective
strategies for stopping this pathogenic resistant bacteria through different targeting mechanisms.
The process of translating these effective molecules into therapeutic drugs is difficult since they
need to be at a higher dose for in vivo effectiveness, which can lead to toxicity. Biofilm
resistance has continued to provide more questions than answers, but expanding research into
bacterial competition with biofilms may provide additional insight that may be missed in other
experiments.
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Variovorax paradoxus Properties
V. paradoxus is a Gram-negative bacterium in the Comamonadaceae family. It gets the
genus name Variovorax (“devouring a variety [of substrates]”) because isolates in this genus
have been found to display various metabolic activities [25]. Interactions of V. paradoxus with
other microbes or plants can be beneficial in creating metabolites for survival or forming a
symbiotic relationship [7, 5].
V. paradoxus isolates can be found in soil or even contaminated soil full of harmful
substances, but due to its unique metabolic functions it is able to thrive by catabolizing those
compounds. Numerous studies have found that it can degrade complex organic compounds or
aromatic compounds as either its sole energy source, carbon source, nitrogen source or sulfur
source. V. paradoxus can also degrade polymers like chitin or cellulose and is often resistant to
metals. Isolates of V. paradoxus contain anabolic capabilities that require additional studies,
such as synthesis of N-acyl-D-amino acid amidohydrolase and α-methylserine aldolase enzymes
useful in commercial pharmaceutical synthesis [25].
Bacterial Competition
Communities of microbes in an environment can form beneficial relationships to ensure
survival or they can compete for resources such as space and nutrients. Many factors can affect
the outcome of these competitive microbial interactions when there are in nutrient sparse
environments the microbes will compete for available nutrients and potentially even target the
other microbes as food sources. These interactions can be affected by the concentration,
behavior, antibiotic production, and motility of microbes observed [8]. By observing two
microbes in a competitive experimental set up, scientists are able to examine the mechanisms
they utilize to compete or inhibit each other. Microbes can outcompete one another which leads
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to death. When microbes inhibit one another, they may be creating a factor termed a secondary
metabolite, a natural product made by bacteria that is not involved in microbe development.
Previous work in the Orwin lab has shown there is anti-Staphylococcus aureus activity by
V. paradoxus in a killing assay, where a surfactant defective mutant strain of V. paradoxus
utilizes S. aureus for nutrients to grow and as a result zones of inhibition were observed. In a
biofilm chamber, adding S. aureus and V. paradoxus simultaneously resulted in a sharply
reduced S. aureus biofilm formation. Although the mechanism has yet been determined two
potential methods in which V. paradoxus is inhibiting S. aureus biofilm is either V. paradoxus
cells are directly attacking S. aureus cells or V. paradoxus is producing a soluble factor affecting
the biofilm of S. aureus.
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Hypothesis
There are two possible mechanisms previously mentioned in which V. paradoxus inhibits
biofilm formation of S. aureus. I hypothesize a soluble factor is the influential factor that is
inhibiting S. aureus biofilm by V. paradoxus when in co-culture. To confirm the mechanism of
inhibition biofilm analysis and transcriptomic analysis will be done.
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CHAPTER 2: MATERIALS AND METHODS

Bacterial Strains and Culture Conditions
V. paradoxus strain (EPS), V. paradoxus mutant strain (VP Mut 35), S. aureus strain, and
E. coli strain used in this study and their growth conditions can be found in Table 1. Bacterial
strains were inoculated from -80℃ glycerol stocks and grown on their respective plates at room
temperature. EPS on YE plates, VP 35 on YE + Kanamycin plates, S. aureus on YE +
Chloramphenicol plates, and E. coli on TSA plates. All overnight cultures were grown in a test
tube with 5ml of YE broth with inoculated bacteria at 30 °C while shaking at 200 rpm New
Brunswick Scientific Classic Series (C24 Incubator Shaker) for 24 hours. For overnight cultures
of S. aureus 5μl of chloramphenicol and VP Mut 35 5μl of Kanamycin was added.
Mono and Co-Culture Biofilm Inhibition (BI) Assay
Overnight cultures grown with antibiotics were washed twice or once if not grown with
antibiotics using YE broth and resuspended in media. Strains were then measured, using the
Genesys 30 visible spectrophotometer (Thermo Scientific), and adjusted to an 𝑂𝐷595 = 3 for S.
aureus and an 𝑂𝐷595 = 1 for E. Coli, EPS, and VP Mut 35. Co-culture biofilms were grown
statically with a slight tilt, using a 10ml serological pipette (Figure 1), on 12-well plates with a
total volume of 500μl per well at room temperature for 48 hours. In 3 wells EPS + S. aureus, the
positive controls contained YE broth only in 3 wells and S. aureus only in 3 wells, and for the
negative control E. coli + S. aureus in 3 wells. Co-cultures were prepared by adding S. aureus at
an 𝑂𝐷595 =0.003 and competitors were added at a final 𝑂𝐷595 =0.1.
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Filtered Biofilm Culture Supernatant (FBCS) Assay
Following the 48-hour co-culture biofilm assay, the culture fluid was obtained for each
well and centrifuged 15000xg for 4 minutes. The supernatant was saved, and pellet discarded.
To ensure no bacterial cells remained it was also syringe filtered (.22 microns). Fresh YE media
was added in a 1:1 ratio of supernatant + 5μl of S. aureus, per 500μl. The negative control
contained 1:1 ratio of fresh YE media and supernatant with no S. aureus. Mixed cultures were
then plated 500μl per well in a 12-well plate with a slight tilt at room temperature for 48 hours.
The filtrate was spotted on YE plates to ensure no viable bacteria remained.
Heat Denatured FBCS Assay
The culture fluid was obtained as previously described in FBCS assay. Once supernatant
was free of bacterial cells it was heat treated at 65ºC on the digital dry block (thermo scientific)
for 60 minutes, followed by a 15-minute rest at 30ºC. Once the supernatant was heat treated and
cooled, fresh YE media was added to the supernatant in a 1:1 ratio + 5μl of S. aureus, per 500μl.
Mixed conditions were set up in 12-well plates using the biofilm tilting method for 48hrs.
Proteinase K Treated FBCS Assay
Thermolabile Proteinase K (New England Biolabs Inc) was added to 1.5ml of FBCS in a
1:100 dilution and incubated at room temperature for 1 hour. The enzyme was heat inactivated
at 55ºC for 10 minutes. Replicate samples without the thermostable proteinase K were treated
identically. The samples were allowed to cool to 30ºC for 15 minutes, and then the S. aureus
inhibition assay was set up as described above. Biofilm inhibition was evaluated after 24h.
Molecular Weight Cutoff Fractionation FBCS Assay
FBCS was obtained as previously described and spot plated to ensure no bacterial cells in
filtrate. A 10,000 molecular weight cut off (MWCO) centrifugal filter (Genesee Scientific) was
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used to separate 3ml of supernatant by centrifugation at 20ºC for 10 minutes at 3234 x g using
the centrifuge 5804R (Eppendorf). The flow through material, approximately 2.5ml, was
obtained in a 15ml conical tube and high molecular weight fraction was placed in a fresh tube
and adjusted to an equal volume with the flow through in sterile deionized water. The FBCS
biofilm inhibition assay was performed as described above, and biofilm formation was evaluated
after 24h.
SDS-PAGE
SDS-PAGE was used to verify the MWCO filtration and proteinase K treatment. For
each sample 100μl was obtained and 100μl of 2x Laemmli buffer + 20μl of 0.5M DTT was
added to each sample. Samples were then loaded and electrophoresed at 120 V for 60 minutes
on the Biorad Mini-PROTEAN tetra system. Coomassie blue was used to stain the proteins in
this gel for 1 hour and then methanol:acetic acid destain was used to visualize the protein bands.
Microscopy
Following the 48-hour co-culture biofilm assay and FBCS assay, unattached bacterial
cells were removed carefully by tilting the 12-well plate away and washing the wells with 1ml
sterile deionized water twice. In each well of the co-culture biofilm assay 1ml of 1μg/ml DAPI
was added and stored in the dark for 10 minutes then washed. For all assays fluorescent images
were obtained using the Echo Revolve microscope (D230 Rev A).
Crystal Violet Staining
Following the assays, unattached bacterial cells were removed carefully by tilting the 12well plate away and washing the wells with 1ml sterile deionized water twice. In each well 1ml
of 1% crystal violet was added and set for 15 minutes before washing three times with deionized
water and inverting to let dry.
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Quantitative Analysis of V. paradoxus and S. aureus
First the crystal violet fixed samples were dissolved with 1ml of 95% ethanol for 15
minutes. Then 100μl of each well sample was plated into a well on a 96-well plate and for the
control, 100μl of 95% ethanol was added to its respective well. Microplate counting was
measured at OD595 using the spectromax 250 and SoftMax Pro software (S 02358).
RNA Extraction
RNA samples were collected from mono and co-culture biofilms were completed. The
samples obtained are planktonic and remaining biofilm scraped from S. aureus + V. paradoxus
co-culture and V. paradoxus monoculture. For the planktonic samples a micro centrifuge tube
was filled with 1ml of supernatant and centrifuged at 15000 g for 4 minutes to pellet. For the
biofilm scraping samples 1ml of YE broth was added to a well #1 and detached the biofilm using
a sterile stock stick. Once biofilm was completely detached, the remaining liquid was removed
and placed into the next well for the remaining 5, repeating this method. At the last well #6,
what remains is 1ml of dense biofilm scrapings. This sample was divided into 250μl samples
and centrifuge at the same speed as before, retaining the pellet. Sample replicates were stored in
the -20 °C. Moving forward with the pellet, the planktonic samples were resuspended in 1ml of
lysis buffer, but only 400μl is needed to move forward with the protocol, and the biofilm
scraping samples were resuspended in 750μl of lysis buffer. The Quick-RNA Miniprep kit from
Zymo Research was used to purify RNA according to the remainder of the manufacturer's
protocol. In the final elution step only 50μl of DNase/RNase free water was used to obtain
highly concentrated RNA. The RNA concentration and purity was measured using the Thermo
scientific NanoDrop 1000 spectrophotometer. Purified samples were sent off to Microbial
Genome Sequencing Center (MiGS) for sequencing and analysis.
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CHAPTER 3: RESULTS

Biofilm Inhibition (BI) Assay
Inhibition of S. aureus biofilm by V. paradoxus was evaluated in a biofilm inhibition (BI)
co-culture assay in 12-well plates with a tilt (Figure 1) grown at room temperature for 48hr.
Biofilm formation was examined by fluorescence microscopy and crystal violet staining.
Monocultures of S. aureus (Figure 2A) display clear and dense biofilm growth, while the
V. paradoxus (Figure 2C) monoculture biofilm growth is present but not as strong. When S.
aureus is in co-culture with E. coli (Figure 2B) it still forms a robust biofilm, but when we
compare this to V. paradoxus co-culture, (Figure 2D) we can see a clear inhibitory effect.
Similarly, when S. aureus is co-cultured with V. paradoxus Mut 35, a surfactant defective strain
(Figure 2E) inhibition is still observed. Crystal violet (CV) fixed biofilms (Figure 3) show the
inhibition in co-culture with V. paradoxus (Figure 3C) or V. paradoxus Mut 35 (Figure 3D)
compared to the dense biofilms in S. aureus monoculture (Figure 3A) and E. coli co-culture
(Figure 3B). The CV staining allows for biofilm quantification and comparison to S. aureus
monocultures. The dense S. aureus monoculture displayed the highest absorbance (Figure 4).
When in co-culture with V. paradoxus the amount of bacteria decreased significantly and coculture with V. paradoxus Mut 35 also had similar levels of decrease. At first glance it seems as
if E. coli co-culture decreased bacteria present in comparison to S. aureus monoculture.
However, this decrease of S. aureus biofilms is not shown in microscopic images or crystal
violet staining (Figure 2, 3). Significance (p<0.0002) using a student's unpaired t-test.
To further investigate this inhibition, a dilution series of either E. coli or V. paradoxus
strains was introduced in co-culture. Biofilm formation is similar in all E. coli co-cultures tested
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(Figure 5B-5D). A dose response was observed in S. aureus biofilm as the amount of V.
paradoxus was decreased in each co-culture. More dilute V. paradoxus can still inhibit S. aureus
biofilm (Figure 5F,5G) the inhibition was reduced as the inoculum was diluted, as observed in
microscopy (Figure 5E-5G) as well as in crystal violet fixed biofilms (Figure 6). Comparison
of S. aureus monocultures, E. coli co-culture biofilms are still formed readily (Figure 6B-D), but
in V. paradoxus co-culture (Figure 5E-G) biofilms are disrupted.
Filtered Biofilm Culture Supernatant (FBCS) Assay
To determine if the occurrence of inhibition is via a secreted compound, culture fluid
from the BI assay was obtained from mono and co-culture conditions.
Across the FBCS assay we can see clear inhibition by V. paradoxus (Figure 7D) and V.
paradoxus Mut 35 in co-culture supernatants (Figure 7E), when compared to monocultures and
E. coli co-cultures (Figures 7A-C). Figure 7C, V. paradoxus monoculture supernatant does not
disrupt biofilm formation. Crystal violet staining (Figure 8) further illustrates the inhibitory
effect of V. paradoxus and V. paradoxus Mut35 co-culture supernatants. Figure 8C, V.
paradoxus monoculture supernatant, S. aureus forms a biofilm. Quantitative analysis on FBCS
assay illustrates that supernatants from S. aureus monoculture had no effect on S. aureus
densities. For V. paradoxus monoculture supernatant and E. coli co-culture supernatant densities
are lower than S. aureus monoculture supernatant but are much higher than the levels of both V.
paradoxus and V. paradoxus Mut 35 supernatant co-cultures. Significance value of p<0.001.
To ensure that this activity is due to the supernatant a 2-fold dilution series was done. In
all dilutions when supernatant is decreased, although S. aureus introduced is kept constant, S.
aureus grows more with each 2-fold dilution (Figure 10). Fixed dilutions images display an
increasing gradient of biofilm formation as inhibitory supernatant is decreased 2, 4, and 8 fold.
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Figure 10A, S. aureus biofilm grows dense and in E. coli supernatant co-culture, S. aureus
biofilm gets denser as supernatant is consistently decreased. Figure 10B may indicate a modest
E. coli inhibitory effect as well. Looking at Figure 10C, V. paradoxus supernatant co-culture
biofilm inhibition is present 2 fold and even 4 fold, but is not as prominent compared to the
undiluted.
Heat Denatured FBCS Assay
We further wanted to explore if the soluble factor responsible for inhibiting biofilm
formation is a heat labile. In crystal violet fixed images there is clear inhibition of biofilm in V.
paradoxus and V. paradoxus Mut 35 co-culture (Figure 11) indicating that the molecule of
interest is heat stable. Quantitative analysis of heat denatured FBCS assay verifies inhibition by
V. paradoxus and V. paradoxus Mut 35 co-culture when comparing to the readings of S. aureus
and V. paradoxus monoculture, and that the effect remains significant after heat treatment
(Figure 12). Significance value of p< 0.03.
Proteinase K Treated FBCS Assay
A thermolabile proteinase K was used to test if the inhibitory secreted compound is a
protein. Figure 13 shows that robust biofilm growth was present in both samples containing S.
aureus biofilm culture fluid (panel A). Testing the proteinase treated culture fluids from cocultures with the two Variovorax strains (Figure 13 B,C), showed that the inhibition was not
sensitive to proteinase K treatment. Quantification of biofilms was done, Figure 14, and
statistical analysis with the student’s unpaired t-test showed p<0.003 for S+V conditions
compared to S. aureus alone tells us that although inhibition of biofilms are statistically
significant in comparison to one another. For the other conditions S and S+35, differences in
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optical densities between treated and untreated samples were found to not be statistically
significant.
Molecular Weight Cutoff Fractionation FBCS Assay
To further examine this inhibitory molecule a centrifugal filter with a molecular weight
cutoff of 10,000 Daltons was used. The flow through, smaller than 10,000 Daltons, and the
remainder in filtrate, larger than 10,000, was tested against S. aureus as usual. In Figure 15,
panel A, S. aureus FBCS, has strong biofilm growth for top and bottom image and in panels BC, co-cultures with both strains of V. paradoxus FBCS, the top images clearly indicate inhibition
of S. aureus biofilm formation in comparison to the bottom images. Quantitative analysis was
done to the fixed biofilms, figure 16, and co-culture levels that were reduced in comparison of
>10,000 Daltons or < 10,000 Daltons was found to be statistically significant (p<0.0001). This
very clearly demonstrates that the inhibitory molecule is smaller than 10,000 Daltons.
SDS-PAGE
SDS-PAGE is done to ensure that proteins in the protein treated assay were properly
removed and separated in molecular weight assays mentioned previously. Results confirm
proteins in the proteinase K treated sample were properly digested and proteins in the molecular
weight were properly filtered.
Transcriptional Expression of V. paradoxus in Mono and Co-culture
RNA sequencing data collected was done by MiGS and differential gene expression
analysis was done using edgeR [23]. To evaluate the response of V. paradoxus in co-culture
with S. aureus, we compared responses to V. paradoxus monoculture, in both planktonic cells
and biofilm cells which were obtained post 48hr biofilm inhibition assay. Transcriptome
analysis reveals an immense difference in gene expression, from mono to co-culture (Figure 17,
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18). In Figure 18 there is a discrepancy in expression for planktonic samples C in mono and coculture compared to biological replicates A and B suggestive of different expression profiles.
For planktonic cells a total 1548 genes were differentially expressed with a false discovery rate
(FDR) of 1%, with 1230 genes being up regulated and 318 genes being down regulated. In
biofilm cells 163 genes were differentially expressed with a FDR of 10%, with 59 genes being
up regulated and 104 genes down regulated. Of the differentially expressed genes, only the top
25 up-regulated genes in planktonic (Table 8) or biofilm cells (Table 7) are shown. Biofilm
upregulated genes show no likely candidates for inhibitory effect. In planktonic differentially
expressed genes there are various upregulated genes which tells us this inhibition is occurring in
the planktonic cells. Table 8 what stands out is the most upregulated gene, alpha fucosidase
VARPA_1431, a sugar degradation enzyme which may be involved in degrading EPS. Other
genes are some type VI secretion system genes like VARPA_0586, VARPA_0565, and
VARPA_0590, which are known to be involved in translocating virulent proteins to bacteria.
Table 9 is a list of 5 amino adenylation domain proteins upregulated but not in the top 25
upregulated genes for planktonic samples. These particular genes are significant to us since they
are associated with non-ribosomal peptide synthase, a secondary metabolite.
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CHAPTER 4: DISCUSSION

Antibiotic resistant bacteria such as S. aureus can grow as a dense biofilm providing
additional defense to antibiotics. The Orwin lab has established that V. paradoxus has anti-S.
aureus activity in liquid and solid co-culture conditions. In this work doing a series of biofilm
inhibition assays we determined the inhibition of S. aureus biofilm is due to a secreted soluble
factor by V. paradoxus when in co-culture.
Biofilm Inhibition of S. aureus
We have shown that S. aureus biofilms are inhibited when in co-culture with V.
paradoxus. In this experiment a defective surfactant strain, V. paradoxus Mut 35, was used to
determine if this mutation is involved in biofilm inhibition. Our results show V. paradoxus and
V. paradoxus Mut 35 both inhibit S. aureus biofilms as observed in microscopic and crystal
violet analysis. Therefore, the surfactant is not what is causing biofilm inhibition, but it could
possibly be involved, in part, to overall disruption. Microscopic images reveal minimal green
fluorescence, S. aureus, when in co-culture with either V. paradoxus strain. The inhibition of the
biofilm by V. paradoxus is easy to see in comparison to the S. aureus monoculture which
developed a dense biofilm over two days as shown by the GFP expression and DAPI staining.
From the dilution series of the co-cultures we see that the amount of V. paradoxus strains present
is correlated to its inhibitory effect. Previous work displaying zones of inhibition and continual
inhibition of S. aureus in this biofilm assay lead us to believe that this inhibition is a result from
a secreted factor produced by V. paradoxus.
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FBCS Inhibition of S. aureus Biofilms
To identify if the inhibition is a direct result of a soluble secreted substance culture fluid,
supernatant, was obtained from biofilm inhibition assays and filtered to remove cells. This
experiment allowed us to determine that in the V. paradoxus co-culture supernatant, S. aureus
biofilm was entirely inhibited and in V. paradoxus monoculture supernatant, the inhibitory effect
is also present but not as strong. Thus, indicating that this inhibitory compound is being
produced more by V. paradoxus when in co-culture with S. aureus as seen in the images.
Furthermore, a dilution series was done to ensure supernatant is responsible for biofilm
disruption and not some other factor. Microscopic images from the assays were less informative
(not shown), but crystal violet fixed images confirm strong inhibition is occurring in a dose
dependent manner, with the strongest effect being the least diluted supernatant. The CV stain is
also useful to produce quantitative analysis of biofilm levels. Across all assays V. paradoxus coculture and V. paradoxus Mut 35 co-culture showed significant inhibition in comparison to S.
aureus monoculture. The data for E. coli co-culture shows a modest reduction in biofilm but it is
not dose dependent and is not as substantial as the inhibition by V. paradoxus co-culture. These
results support our hypothesis that V. paradoxus is creating a soluble factor that is disrupting S.
aureus biofilm when in co-culture.
Additional analysis of this soluble compound was done to obtain information regarding
the characteristics of this inhibitory molecule. We attempted to examine if this active molecule
is heat labile by using the same experimental set up previously done and heating up the filtered
supernatant to 65º C for 1 hour, which in most proteins will cause unfolding and denaturing.
Crystal violet staining of samples indicates inhibition of biofilm formation, so the molecule of
interest is heat stable up to 65º C. To further probe the possibility of it being a
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protein, proteinase K treatment of V. paradoxus co-culture supernatant in comparison to
untreated samples was examined. Analysis of this data revealed no major differences in biofilm
inhibition leading us to believe the active molecule is not a protein. A molecular weight cut off
experiment was used to further examine the nature of the inhibitory compound. The data from
this experiment supports the contention that this soluble inhibitory molecule is smaller than
10,000 Daltons. Taken together, these results contribute to characteristics of this inhibitory
active molecule which is heat stable, not a protein, and is smaller than 10,000 Daltons.
Transcriptome
Transcriptome analysis reveals a larger proportion of differentially expressed genes in
planktonic than the biofilm samples. This indicates that in this experimental setup inhibition is
occurring via the planktonic cells rather than the biofilm cells. In the planktonic samples
VARPA_1431, a predicted alpha fucosidase, had the highest LogFC value. Since it can be
involved in degrading EPS it is plausible that this protein is involved in part of inhibiting S.
aureus biofilm. Additionally, a few type VI secretion system genes like VARPA_0586,
VARPA_0565, and VARPA_0590 were upregulated as well. These are of particular interest
since they are involved in killing other bacteria by virulent proteins. There are 15 other type VI
secretion system genes that were also upregulated in the presence of S. aureus in planktonic
samples. There are also 5 amino acid adenylation domain proteins; VARPA_2887-88,
VARPA_4324-25, and VARPA_4327, which are non-ribosomal peptide synthases, involved in
the synthesis of secondary metabolites. The specific upregulation of these genes in the coculture
experiments leads to the possibility of the soluble factor inhibiting biofilm being the product of
these genes. This is consistent with other work on bacterial secondary metabolites being
commonly synthesized using these types of proteins. Previous lab work looking at anti-S. aureus
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activity via V. paradoxus did not reveal upregulation of these non-ribosomal synthases, nor were
these genes upregulated in V. paradoxus monoculture biofilms. So, of the possible mechanisms
shown by the upregulated genes mentioned, which may be involved in part to the overall
inhibition of biofilm, the strongest indicator of this inhibitory effect are the production of these
secondary metabolites that were not previously identified.
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CHAPTER 5: CONCLUSION

In this study we tested whether S. aureus in co-culture with V. paradoxus would affect S.
aureus biofilm. Using our biofilm assays we were able to show that in co-culture V. paradoxus,
biofilm typically created by S. aureus were inhibited. FBCS assays revealed that this inhibition
is occurring through a soluble factor V. paradoxus is creating and this factor was produced more
when in co-culture with S. aureus indicating a response from V. paradoxus. Characteristics of
this soluble molecule were identified to be heat stable, not a protein, and smaller than 10,000
Daltons. Planktonic transcriptomic data showed potential candidates for this inhibitory effect.
Revealing of particular interest, a set of upregulated non-ribosomal peptide synthases not
previously seen before in the Orwin lab. Taking the characteristics of this molecule into
consideration with the transcriptomic data it is very likely that this inhibitory molecule is a
secondary metabolite.
Ultimately, this study forms a basis for future experiments to identify this inhibitory
soluble molecule. This can be done a number of ways such as doing mass spectrometry or by
knocking out the potential candidates listed here and see if activity still occurs. In the long term
this research will create an opportunity to utilize the molecule as a surfactant or even a
therapeutic agent.
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APPENDIX A: FIGURES

Figure 1. Example of biofilm tilt set up for all assays performed. Tilt was achieved using a 10 ml
serological pipette.
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Figure 2. Microscopy biofilm inhibition (BI) assays. Following the 48hr and DAPI staining,
which stains DNA blue and the green fluorescent is from GFP expressing S. aureus. Microscopic
images were obtained at 100X. A) S. aureus monoculture, B) E. coli + S. aureus co-culture, and
C) V. paradoxus monoculture, D) V. paradoxus + S. aureus co-culture, E) V. paradoxus Mut 35
+ S. aureus co-culture.
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Figure 3. Crystal violet fixed biofilm inhibition assay. 1% Crystal violet stain was used to fix
bacteria onto wells for quantitative analysis. The following images are representatives of biofilm
formation in the conditions: A) S. aureus monoculture, B) E. coli + S. aureus co-culture, and C)
V. paradoxus monoculture, D) V. paradoxus + S. aureus co-culture, E) V. paradoxus Mut 35 +
S. aureus co-culture.
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Figure 4. Quantitative analysis - BI assay. To quantify the bacteria present in BI samples optical
densities taken of crystal violet fixed samples using the spectrophotometer at 595 nm for
biological replicates of mono and co-culture conditions. Average of samples are shown and
statistical analysis was done, unpaired T-test, values are <0.0001 so null hypothesis cannot be
rejected.
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Figure 5. Microscopy biofilm inhibition assay- dilution series. Following the 48hr growth period
and DAPI staining, microscopic images were obtained at 100X. A) S. aureus monoculture, B)-D)
E. coli + S. aureus co-culture from left to right; undiluted, 2 fold, 4 fold, and E)-G) V.
paradoxus + S. aureus co-culture from left to right; undiluted, 2 fold, 4 fold.
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Figure 6. Crystal violet fixed biofilm inhibition assay- dilution series. 1% Crystal violet fixed
bacteria. The following images are representatives of a diluted series of biofilm formation: A) S.
aureus monoculture, B)-D) E. coli + S. aureus co-culture from left to right; undiluted, 2 fold, 4
fold, and E)-G) V. paradoxus + S. aureus co-culture from left to right; undiluted, 2 fold, 4 fold.
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Figure 7. Microscopy FBCS assay. Following the 48hr period and wells were washed
microscopic images were obtained at 100X. A) S. aureus monoculture, B) E. coli + S. aureus coculture, C) V. paradoxus monoculture, D) V. paradoxus + S. aureus co-culture, E) V. paradoxus
Mut 35 + S. aureus co-culture.
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Figure 8. Crystal violet fixed FBCS assay. 1% Crystal violet stain was used to fix bacteria onto
wells for quantitative analysis. The following images are representatives of biofilm formation:
A) S. aureus monoculture, B) E. coli + S. aureus co-culture, and C) V. paradoxus monoculture,
D) V. paradoxus + S. aureus co-culture, E) V. paradoxus Mut 35 + S. aureus co-culture.

Figure 9. Quantitative analysis - FBCS assay. To quantify the bacteria present in crystal violet
fixed samples, optical densities taken at 595 nm for biological replicates of mono and co-culture
conditions. Average of the samples are shown and statistical analysis was done, unpaired T-test,
values are <0.001 so null hypothesis cannot be rejected.
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Figure 10. Crystal violet fixed FBCS assay- dilution series. 1% Crystal violet fixed bacteria. The
following images are representatives of a diluted series of biofilm formation: A) S. aureus
monoculture from left to right; undiluted, 2 fold, 4 fold, 8 fold, B) E. coli + S. aureus co-culture
from left to right; undiluted, 2 fold, 4 fold, 8 fold, and C) V. paradoxus + S. aureus co-culture
from left to right; undiluted, 2 fold, 4 fold, 8 fold.
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Figure 11. Crystal violet fixed, heat denatured FBCS assay. 1% Crystal violet fixed bacteria. The
following images are representatives of a heat treated FBCS assay of biofilm formation: A) S.
aureus monoculture, B) V. paradoxus + S. aureus co-culture, C) V. paradoxus Mut 35 + S.
aureus co-culture, and D) V. paradoxus monoculture.

Figure 12. Quantitative analysis - heat denatured FBCS assay. Quantification of crystal violet
fixed bacteria was taken by reading the optical densities at 595 nm for biological replicates of
mono and co-culture conditions. Average of the samples are shown and statistical analysis was
done, unpaired T-test, values are <0.03 so null hypothesis cannot be rejected.
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Figure 13. Crystal violet fixed proteinase K treated FBCS assay. Left (treated) right (untreated):
A) S. aureus monoculture B) V. paradoxus + S. aureus co-culture C) V. paradoxus Mut 35 + S.
aureus co-culture
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Figure 14. Quantitative analysis of proteinase K treated FBCS assay. Quantification of crystal
violet fixed bacteria was taken with optical densities at 595 nm for biological replicates of mono
and co-culture conditions. Average of the samples are shown and statistical analysis was done,
unpaired T-test, values are <0.005 for S+V conditions so null hypothesis cannot be rejected.
Samples S and S+35 statistical analysis is rejected. Samples without brackets (i.e. S) are treated
with proteinase K and samples with brackets (i.e. [S]) are untreated.
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Figure 15. Crystal violet fixed molecular weight cutoff fractionation FBCS assay. Top (flow
through) bottom (remained in filter): A) S. aureus monoculture B) V. paradoxus + S. aureus coculture C) V. paradoxus Mut 35 + S. aureus co-culture
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Figure 16. Quantitative analysis of molecular weight cutoff fractionation FBCS assay.
Quantification of crystal violet fixed bacteria was taken with optical densities at 595 nm for
biological replicates of mono and co-culture conditions. Average of the samples are shown and
statistical analysis was done, unpaired T-test, values are <0.0001 for co-cultures so null
hypothesis cannot be rejected. Samples with prime symbol (i.e. S’) are what remained in the
filtrate and samples without the prime symbol (i.e. S) is the flow through from the 10,000
molecular weight filter.
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Figure 17. Biofilm heatmap. Relative gene expression at Log2 base, in biofilm bacterial cells for
3 biological replicates (A, B, C) when comparing V. paradoxus monoculture vs V. paradoxus +
S. aureus co-culture.
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Figure 18. Planktonic heatmap. Relative gene expression at a Log2 base, in planktonic bacterial
cells for 3 biological replicates (A, B, C) when comparing V. paradoxus monoculture vs V.
paradoxus + S. aureus co-culture.
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APPENDIX B: TABLES

Table 1
Strains

Source

Growth conditions

Variovorax paradoxus EPS
Wild type

Paul Orwin, University of
the Pacific

30 ºC
YE agar (5g/L + 1.5%) or YE
broth (5g/L)

Variovorax paradoxus EPS
Mutant 35
𝚫4519 (KmR)

Paul Orwin, University of
the Pacific

30 ºC
YE agar (5g/L + 1.5%) +
Kanamycin 0.05g/ml or YE
broth (5g/L) + Kanamycin
0.05g/ml

Staphylococcus aureus
Alexander Horswill,
AH1710=S. aureus RN4220 + University of Iowa
pCM29 CmR
(PsarA_RBSsod_SGFP)

30 ºC
TSA agar (40g/L) +
Chloramphenicol 0.03g/L
or YE broth (5g/L) +
Chloramphenicol 0.03g/L

Escherichia coli
Top 10 F’

30 ºC
YE agar (5g/L + 1.5%) or YE
broth (5g/L)

Daniel Nickerson, CSU San
Bernardino

Bacterial strains and conditions. All strains were grown at 30 ºC.
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Table 2
1

2

3

4

5

6

7

8

9

Sample

3.63

3.60

3.60

3.61

3.60

3.63

3.51

3.57

3.60

S

1.31

0.92

1.39

1.01

0.93

1.09

1.02

0.91

1.03

S+E

0.20

0.21

0.20

0.17

0.16

0.16

0.14

0.15

0.15

S+V

0.22

0.16

0.16

0.18

0.16

0.15

0.15

0.14

0.16

VP

0.18

0.17

0.18

0.22

0.24

0.26

0.22

0.29

0.23

S+35

0.07

0.07

0.07

0.07

0.07

0.07

0.07

0.07

0.07

Eth.

Quantitative results - BI assay. Crystal violet density measurements taken at OD 595 nm. The
last row is reading of ethanol only, as wells were dissolved using ethanol to take measurements.
The remainder of samples are biological replicates according to their sample type.
Table 3
1

2

3

Sample

3.62

3.60

3.44

S

2.03

2.43

1.92

S+E

0.14

0.12

0.11

S+V

1.08

0.77

0.75

VP

0.12

0.10

0.10

S+35

0.08

0.07

0.07

Eth.

Quantitative results - FBCS assay. Crystal violet density measurements taken at OD 595 nm. The
last row is readings of ethanol only, as wells were dissolved using ethanol to take measurements.
For the remainder of samples there are 3 biological replicates according to their sample type.
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Table 4
1

2

3

Sample

1.92

2.10

2.46

S

0.30

0.29

0.26

S+V

0.12

0.13

0.11

S+35

1.42

1.37

0.68

V

0.07

0.07

0.07

Ethanol

Quantitative results - Heat denatured FBCS assay. Crystal violet density measurements taken at
OD 595 nm. The last row is readings of ethanol only, as wells were dissolved using ethanol to
take measurements. For the remainder of samples there are 3 biological replicates according to
their sample type.

Table 5
1

2

3

4

5

6

Sample

2.30

2.52

1.95

1.57

1.86

2.30

S

2.34

2.56

2.27

2.30

2.02

2.17

[S]

0.16

0.13

0.14

0.16

0.17

0.19

S+V

0.23

0.22

0.23

0.26

0.22

0.16

[S+V]

0.11

0.11

0.11

0.11

0.11

0.11

S+35

0.12

0.12

0.11

0.13

0.10

0.14

[S+35]

0.07

0.07

0.08

0.07

0.07

0.07

Ethanol

Quantitative results - Protein treated FBCS assay. Crystal violet density measurements taken at
OD 595 nm. Remainder of samples are biological replicates according to their conditions.
Samples within brackets are untreated and without brackets are treated with proteinase K.
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Table 6
1

2

3

4

5

6

7

8

9

Sample

3.07

3.28

2.71

3.45

2.33

2.47

2.84

2.91

2.59

S

2.94

3.00

2.96

2.81

3.06

2.54

3.09

2.40

2.59

S’

0.13

0.11

0.11

0.11

0.11

0.13

0.10

0.12

0.10

S+V

1.71

2.01

1.97

2.62

2.43

2.54

2.79

2.11

2.57

S+V’

0.24

0.20

0.19

0.25

0.26

0.26

0.25

0.22

0.21

S+35

3.05

3.24

3.13

1.96

2.69

3.00

3.19

2.93

3.19

S+35’

0.07

0.08

0.07

0.07

0.07

0.07

0.08

0.07

0.07

Ethano
l

Quantitative results - Molecular weight FBCS assay. Crystal violet density measurements taken
at OD 595 nm. Remainder of samples are biological replicates according to their conditions.
Samples with prime symbols are what remained in the filter and without prime is the flow
through from 10,000 molecular weight filters.
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Table 7

Overexpressed proteins from biofilm transcripts. A total of 163 genes were differentially
expressed in biofilm bacterial cells, but only the top 25 are shown. P < 0.05
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Table 8

Overexpressed proteins from planktonic transcripts. A total of 1548 genes were differentially
expressed in planktonic bacterial cells, but only the top 25 are shown. P < 0.01
Table 9

Significant up-regulated genes in planktonic transcripts. 5 significant upregulated amino acid
adenylation domain proteins found in planktonic cells, not in the top 25, with LogFC values
ranging from 1.45-3.3. P< 0.01

